At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 22 enrolled
Drug / intervention
2.5 g of lidocaine 23% / tetracaine 7% ointment without occlusion +1 moredrug
Likely dose
2.5 g of lidocaine 23% / tetracaine 7% ointment without occlusionfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Randomized, Double-blinded, Split-face Study Comparing Efficacy of Lidocaine 2.5%/Prilocaine 2.5% Cream Under Occlusion, and Lidocaine 23% /Tetracaine 7% Ointment for Anesthesia Prior to 1927nm Fractional Laser Treatment
In Brief
A Phase 3 clinical trial evaluating 2.5 g of lidocaine 23% / tetracaine 7% ointment without occlusion and 7.5 g lidocaine 2.5%/ prilocaine 2.5% cream with occlusion for Anesthesia, Local and 2 related conditions. Completed, enrolled 22 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the efficacy of lidocaine 2.5%/prilocaine 2.5% cream versus lidocaine 23%/tetracaine 7% ointment for topical anesthesia prior to a nonablative laser procedure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
202120222023202420252026
First PostedAug 2020
Enrollment StartJan 2021
Primary CompletionFeb 2025
TodayJul 2026
First PostedAug 24, 2020
Enrollment StartJan 8, 2021
Primary CompletionFeb 19, 2025
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 5.9 years ago
Interventions
2.5 g of lidocaine 23% / tetracaine 7% ointment without occlusiondrug
Topical anesthetic used to numb the skin prior to laser procedures
7.5 g lidocaine 2.5%/ prilocaine 2.5% cream with occlusiondrug
Topical anesthetic used to numb the skin prior to laser procedures